(2S)-1-(morpholin-4-yl)propan-2-ol - CAS 65617-17-6
Catalog: |
BB059148 |
Product Name: |
(2S)-1-(morpholin-4-yl)propan-2-ol |
CAS: |
65617-17-6 |
Synonyms: |
(S)-α-Methyl-4-morpholineethanol; (αS)-α-Methyl-4-morpholineethanol; (S)-3-Morpholino-2-propanol |
IUPAC Name: | (2S)-1-morpholin-4-ylpropan-2-ol |
Description: | (2S)-1-(morpholin-4-yl)propan-2-ol (cas# 65617-17-6) is a useful research chemical. It is used in the preparation of β-amino alcohols via reduction of lactamides derived from lactate with borane-Me sulfide. |
Molecular Weight: | 145.19 |
Molecular Formula: | C7H15NO2 |
Canonical SMILES: | CC(CN1CCOCC1)O |
InChI: | InChI=1S/C7H15NO2/c1-7(9)6-8-2-4-10-5-3-8/h7,9H,2-6H2,1H3/t7-/m0/s1 |
InChI Key: | YAXQOLYGKLGQKA-ZETCQYMHSA-N |
References: | Lewis, F. W., et al. Synlett, 12, 1923-1928 (2009). |
GHS Hazard Statement: | H300 (50%): Fatal if swallowed [Danger Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P264+P265, P270, P271, P280, P301+P316, P302+P352, P304+P340, P305+P354+P338, P317, P319, P321, P330, P332+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
EP-2334378-A2 | Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use | 20080819 |
WO-2010022177-A2 | Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use | 20080819 |
EP-1658280-A1 | Quinazoline derivatives as angiogenesis inhibitors | 20030806 |
US-2008058342-A1 | Quinazoline Derivatives As Angiogenesis Inhibitors | 20030806 |
US-2012046300-A1 | Quinazoline Derivatives as Angiogenesis Inhibitors | 20030806 |
US-7989460-B2 | Quinazoline derivatives as angiogenesis inhibitors | 20030806 |
WO-2005014582-A1 | Quinazoline derivatives as angiogenesis inhibitors | 20030806 |
NL-1024779-C2 | Combined administration of an indolinone with a chemotherapeutic agent for cell proliferation disorders. | 20021115 |
EP-1474420-A1 | Quinazoline compounds | 20020201 |
EP-2292615-A1 | Quinazoline compounds | 20020201 |
Complexity: | 91.6 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 1 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 145.110278721 |
Formal Charge: | 0 |
Heavy Atom Count: | 10 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 145.110278721 |
Rotatable Bond Count: | 2 |
Topological Polar Surface Area: | 32.7Ų |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | -0.4 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
-
[14245-62-6]
Isopropyl ethanesulfonate
-
[44994-28-7]
N,N,N',N'-Tetramethyl-1,5-pentanediamine
-
[55382-52-0]
Methyl Divarinolcarboxylate
-
[1184173-73-6]
MK-8353
-
[891016-02-7]
ML-SI3
-
[132182-92-4]
Pentane, 1,1,1,2,2,3,4,5,5,5-decafluoro-3-methoxy-4-(trifluoromethyl)-
INDUSTRY LEADERS TRUST OUR PRODUCTS